CLEVELAND, Jan. 10, 2011 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced that it has been awarded a Phase III device study by a new European client, a leading global healthcare supplier.
"We are extremely pleased to welcome this newest European client, as it is particularly rewarding to see long-term relationships flourish into real business opportunities," said Laurence P. Birch, DATATRAK's Chairman and CEO. "DATATRAK confidently marches toward becoming the clinical enterprise solution to safely accelerate every drug, every biologic and every device from concept to cure, and we look forward to delivering eClinical excellence through DATATRAK ONE™ to all of our clients in what continues to be a complex and challenging industry."
DATATRAK eClinical™ is a unified, end-to-end clinical trial solution. By implementing a flexible, permission-based platform, DATATRAK is able to layer modules that support the clinical trial process, from planning to submission as well as integrate with third-party data sources. This unified technology provides one database, one interface and one point of access to all clinical trial activities.
About DATATRAK International, Inc.
DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery in DATATRAK ONE™, the seamless delivery of product and services. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK eClinical™ software solution, deployed worldwide through an ASP or Enterprise Transfer offering, has successfully supported hundreds of international clinical trials involving thousands of clinical research sites and encompassing tens of thousands of patients in 67 countries. DATATRAK has offices located in Cleveland, Ohio, and Bryan, Texas. For more information, visit http://www.datatrak.net.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's quarterly report filed with the Pink OTC Markets on November 12, 2010 announcing its results for the three-month period ending September 30, 2010. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.
Advertisement
"We are extremely pleased to welcome this newest European client, as it is particularly rewarding to see long-term relationships flourish into real business opportunities," said Laurence P. Birch, DATATRAK's Chairman and CEO. "DATATRAK confidently marches toward becoming the clinical enterprise solution to safely accelerate every drug, every biologic and every device from concept to cure, and we look forward to delivering eClinical excellence through DATATRAK ONE™ to all of our clients in what continues to be a complex and challenging industry."
Advertisement
DATATRAK eClinical™ is a unified, end-to-end clinical trial solution. By implementing a flexible, permission-based platform, DATATRAK is able to layer modules that support the clinical trial process, from planning to submission as well as integrate with third-party data sources. This unified technology provides one database, one interface and one point of access to all clinical trial activities.
About DATATRAK International, Inc.
DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery in DATATRAK ONE™, the seamless delivery of product and services. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK eClinical™ software solution, deployed worldwide through an ASP or Enterprise Transfer offering, has successfully supported hundreds of international clinical trials involving thousands of clinical research sites and encompassing tens of thousands of patients in 67 countries. DATATRAK has offices located in Cleveland, Ohio, and Bryan, Texas. For more information, visit http://www.datatrak.net.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's quarterly report filed with the Pink OTC Markets on November 12, 2010 announcing its results for the three-month period ending September 30, 2010. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.
